Table 3.
Clinical information for patients in three groups.
| Total | ABMR | TCMR | STA | P value | ||
|---|---|---|---|---|---|---|
| Age,year | 40.89 ± 12.81 | 37.33 ± 14.05 | 39.33 ± 7.37 | 46 ± 18.52 | 0.743 | |
| Sex | Male | 6 | 2 | 1 | 3 | 0.679 |
| Female | 3 | 1 | 2 | 0 | ||
| Donor kidney source | deceased-donor kidney | 6 | 3 | 1 | 2 | 0.679 |
| related-donor kidney | 3 | 0 | 2 | 1 | ||
| DSA | Positive | 4 | 2 | 1 | 1 | 1 |
| Negative | 5 | 1 | 2 | 2 | ||
| HLA match | <50% | 6 | 3 | 1 | 2 | 0.679 |
| ≥50% | 3 | 0 | 2 | 1 | ||
| Transplatotion, year | 4.78 ± 2.05 | 6.67 ± 0.58 | 4 ± 2.65 | 3.67 ± 1.16 | 0.138 | |
| DGF | Yes | 0 | 0 | 0 | 0 | – |
| No | 9 | 3 | 3 | 3 | ||
| Immunotherapy regimen | Triple-drug immunosuppression | 4 | 2 | 1 | 1 | 1 |
| Triple-drug immunosuppression + Sirolimus | 2 | 0 | 1 | 1 | ||
| Triple-drug immunosuppression + Iguratimod | 1 | 1 | 0 | 0 | ||
| Other | 2 | 0 | 1 | 1 |